Jasper Therapeutics, Inc.

Ownership Transactions Reported by 24 Insiders

Symbol
JSPR, JSPRW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
2200 Bridge Pkwy Suite #102, Redwood City, CA

Insiders trading volume in the past year

Jasper Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Velan Capital Investment Management LP 10%+ Owner $18.6M +$4.53M +32.3% Feb 8, 2024
Carlyle Group Inc. Former 10% Owner $13.8M +$2.46M +21.7% Feb 8, 2024
Qiming U.S. Healthcare Fund II, L.P. 10%+ Owner $5.53M Jan 27, 2023
Roche Holding Ltd 10%+ Owner $2.95M Jan 25, 2023
Balaji Venkataraman Former Director And Officer $1.49M Sep 24, 2021
Kenneth F. Clifford Former Officer $1.49M Sep 24, 2021
Amplitude Healthcare Holdings LLC 10%+ Owner $1.49M Sep 24, 2021
Howard I. Hoffen Former Director $1.49M Sep 24, 2021
Jeetinder Singh Mahal Chief Operating Officer $1.13M -$64.6K -5.39% Sep 12, 2024
Ron Martell President, CEO and Director, Director $215K Jun 10, 2024
William Lis Director $34.7K Oct 13, 2023
Thomas G. Wiggans Director $32.4K Jun 6, 2024
Edwin Jonathan Tucker Chief Medical Officer $1.67K Jun 7, 2024
Abingworth LLP 10%+ Owner Mar 21, 2022
Chris Nolet Director Jun 6, 2024
Scott C. Brun Director Jun 6, 2024
Lawrence Klein Director Jun 7, 2023
Anna Louise French Director Jun 6, 2024
Judith Anne Shizuru Director Jun 6, 2024
Vishal Kapoor Director Jun 6, 2024
Herb Cross Chief Financial Officer Feb 15, 2024
Kurt Von Emster Director Jun 6, 2024
Kevin N. Heller Executive Vice President, Research and Development Mar 21, 2022
Svetlana Lucas Director Jun 18, 2024

Recent Insider Transactions by Companies or Individuals for Jasper Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.